A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence

Table 2 Primary and secondary outcomes at baseline and completion of the study. Between-group analysis was performed

	Control Group (N = 16)	Treatment Group (N = 16)	P-value
UDI-6 score before (mean ± SD)	43 ± 18	45 ± 21	0.77
UDI-6 score after (mean ± SD)	33 ± 26	29 ± 22	0.69
UDI-6 score change (mean ± SD)	-10 ± 31	-16 ± 25	0.58
IIQ-7 score before (mean ± SD)	48 ± 23	50 ± 30	0.76
IIQ-7 score after (mean ± SD)	40 ± 28	30 ± 21	0.31
IIQ-7 score change (mean ± SD)	-8 ± 30	-20 ± 27	0.25
Maximum vaginal squeeze pressure before (cmH₂O, mean ± SD)	36 ± 18	30 ± 15	0.27
Maximum vaginal squeeze pressure after (cmH₂O)	41 ± 21	45 ± 28	0.71
Change in vaginal squeeze pressure (cmH₂O, mean ± SD)	5 ± 12	15 ± 15	0.04
Oxford Scale before (mean ± SD)	2.4 ± 0.8	2.2 ± 0.6	0.51
Oxford Scale after (mean ± SD)	2.9 ± 0.5	2.8 ± 0.5	0.53
Oxford Scale change (mean ± SD)	0.5 ± 0.7	0.6 ± 0.5	0.78
PGI-S score before (mean ± SD)	2.8 ± 0.8	3.1 ± 0.8	0.31
PGI-S score after (mean ± SD)	2.6 ± 0.8	2.3 ± 0.8	0.19
PGI-S score change (mean ± SD)	-0.2 ± 0.9	-0.8 ± 0.8	0.04
PGI-I score (mean ± SD)	2.4 ± 1.0	2.6 ± 0.9	0.61

Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Patient Global Impression of Severity and Improvement question (PGI-S and PGI-I)

ISSN: 1472-6874